Molecular targets in gastric cancer for nanomedicine therapeutics: mechanistic insights and translational progress
Nanomedicine holds strong potential to transform gastric cancer therapy through selective, target-driven interventions. However, successful translation requires better molecular stratification, deeper insight into nano - bio interactions, standardized toxicity evaluation, and scalable manufacturing. Integrating genomics, biomarkers, and AI-driven design will be crucial for developing nanotherapeutics that address specific molecular vulnerabilities in gastric cancer.
Authors
- Taha Y. Alqahtani
- Humood Al Shmrany
- Prashant Kesharwani
- Amirhossein Sahebkar
- Khang Wen Goh
- Mohd Saeed
- Garima Gupta
Institutions
- Lovely Professional University (IN)
- INTI International University (MY)
- Prince Sattam Bin Abdulaziz University (SA)
- Mashhad University of Medical Sciences (IR)
- Asia University (JP)
- Graphic Era University (IN)
- King Khalid University (SA)
- Saveetha University (IN)
- Dr. Hari Singh Gour University (IN)
Publication Details
- Journal
- Expert Opinion on Therapeutic Targets
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1080/14728222.2026.2620601
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00